Researcher Profile

Ronald D’Amico

🏛 From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) — both in the United Kingdom; EPIMED, Berlin (K.A.); Fundación Jiménez Díaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); Hôpital Saint Antoine, Paris (P.-M.G.), and Hôpital Européen, Marseille (P. Philibert) — both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health...

Publications

617

Citations

Co-Authors

Active Years

Publications

Open Access Journal Article Clinical Infectious Diseases Jun 21, 2023

Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure

Chloe Orkin · Jonathan M Schapiro · Carlo F Perno · Daniel R Kuritzkes +19 more

10.1093/cid/ciad370 108 citations

Open Access Journal Article Clinical Infectious Diseases Jan 20, 2023

Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study